Amiloride and guggulsterone suppression of esophageal cancer cell growth in vitro and in nude mouse xenografts

Abstract

Esophageal adenocarcinoma is increasing in the US and Western countries and frequent gastresophageal reflux or gastresophageal reflux disease carrying gastric acid and bile acid could contribute to esophageal adenocarcinogenesis. This study was designed to detect the expression of gastric acid-inducing gene Na⁺/H⁺ exchanger-1 (NHE-1) ex vivo and then to explore targeting of NHE-1 expression or activity to control esophageal cancer cell viability in vitro and in nude mouse xenografts. The data showed that NHE-1 was highly expressed in esophageal adenocarcinoma tissues (66 of 101 cases [65.3%], but not in normal esophageal squamous cell epithelium (1 of 26 cases [3.8%]). Knockdown of NHE-1 expression using NHE-1 shRNA or inhibition of NHE-1 activity using the NHE-1 inhibitor amiloride suppressed viability and induced apoptosis in esophageal cancer cells. Molecularly, amiloride inhibited expression of cyclooxygenase-2 and matrix metallopeptidase-9 but not NHE-1 mRNA in esophageal cancer cells. A combination of amiloride and guggulsterone (a natural bile acid receptor inhibitor) showed more than additive effects in suppressing esophageal cancer cell growth in vitro and in nude mouse xenografts. This study suggests that inhibition of NHE-1 expression or activity or combination of amiloride and guggulsterone could be useful in control of esophageal adenocarcinoma.

Key words： esophageal cancer; NHE-1; amiloride; guggulsterone; cell viability

Acknowledgements

We thank the Department of Scientific Publications at MD Anderson Cancer Center for editing the manuscript. This work was supported in part by a grant from National Cancer Institute Grant R01 CA117895 and a grant from the Duncan Family Institute for Cancer Prevention and Risk Assessment, MD Anderson Cancer Center.

Compliance with ethics guidelines

The authors declare no conflict of interest in this work.

References

1 Blot W J (1994). Esophageal cancer trends and risk factors. Semin Oncol, 21(4): 403-410

PMID

2 Chen X, Yang C S (2001). Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis, 22(8): 1119-1129

PMID

3 Evans D M, Sloan Stakleff K D (2004). Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination. Clin Exp Metastasis, 21(4): 339-346

PMID

4 Evans D M, Sloan-Stakleff K D, Arvan M, Guyton D P (1998). Time and dose dependency of the suppression of pulmonary metastases of rat mammary cancer by amiloride. Clin Exp Metastasis, 16(4): 353-357

PMID

5 Falk G W (2009). Risk factors for esophageal cancer development. Surg Oncol Clin N Am, 18(3): 469-485

PMID

6 Fitzgerald R C, Bishr Omary M, Triadafilopoulos G (1998). Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett’s esophagus. Am J Physiol Gastrointest Liver Physiol, 275: 47-55

7 Fitzgerald R C, Omary M B, Triadafilopoulos G (1997). Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett’s esophagus. J Cell Sci, 110(Pt 5): 663-671

PMID

8 Fliegel L, Dyck J R, Wang H, Fong C, Haworth R S (1993). Cloning and analysis of the human myocardial Na⁺/H⁺ exchanger. Mol Cell Biochem, 125(2): 137-143

PMID

9 Fujiwara Y, Higuchi K, Takashima T, Hamaguchi M, Hayakawa T, Tominaga K, Watanabe T, Oshitani N, Shimada Y, Arakawa T (2006). Roles of epidermal growth factor and Na⁺/H⁺ exchanger-1 in esophageal epithelial defense against acid-induced injury. Am J Physiol Gastrointest Liver Physiol, 290(4): G665-G673

PMID

10 Guan B X, Li H, Yang Z D, Hoque A, Xu X C (2013). Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts. Cancer, 119(7): 1321-1329

PMID

11 Jaiswal K, Tello V, Lopez-Guzman C, Nwariaku F, Anthony T, Sarosi G A Jr (2004). Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett’s adenocarcinoma cell line. Surgery, 136(2): 160-168

PMID

12 Jenkins G J, Harries K, Doak S H, Wilmes A, Griffiths A P, Baxter J N, Parry J M (2004). The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis, 25(3): 317-323

PMID

13 Jiang Z R, Gong J, Zhang Z N, Qiao Z (2006). Influence of acid and bile acid on ERK activity, PPARgamma expression and cell proliferation in normal human esophageal epithelial cells. World J Gastroenterol, 12(15): 2445-2449

PMID

14 Li S, Bao P, Li Z, Ouyang H, Wu C, Qian G (2009). Inhibition of proliferation and apoptosis induced by a Na+/H+ exchanger-1 (NHE-1) antisense gene on drug-resistant human small cell lung cancer cells. Oncol Rep, 21(5): 1243-1249

PMID

15 Loo S Y, Chang M K, Chua C S, Kumar A P, Pervaiz S, Clement M V (2012). NHE-1: a promising target for novel anti-cancer therapeutics. Curr Pharm Des, 18(10): 1372-1382

PMID

16 Masereel B, Pochet L, Laeckmann D (2003). An overview of inhibitors of Na(+)/H(+) exchanger. Eur J Med Chem, 38(6): 547-554

PMID

17 Menges M, Müller M, Zeitz M (2001). Increased acid and bile reflux in Barrett’s esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol, 96(2): 331-337

PMID

18 Newell K, Wood P, Stratford I, Tannock I (1992). Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours. Br J Cancer, 66(2): 311-317

PMID

19 Ouyang H, Bai X, Huang W, Chen D, Dohi S, Zeng W (2012). The antinociceptive activity of intrathecally administered amiloride and its interactions with morphine and clonidine in rats. J Pain, 13(1): 41-48

PMID

20 Putney L K, Denker S P, Barber D L (2002). The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol, 42(1): 527-552

PMID

21 Reshkin S J, Bellizzi A, Caldeira S, Albarani V, Malanchi I, Poignee M, Alunni-Fabbroni M, Casavola V, Tommasino M (2000). Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J, 14(14): 2185-2197

PMID

22 Slepkov E, Fliegel L (2002). Structure and function of the NHE1 isoform of the Na+/H+ exchanger. Biochem Cell Biol, 80(5): 499-508

PMID

23 Sparks R L, Pool T B, Smith N K R, Cameron I L (1983). Effects of amiloride on tumor growth and intracellular element content of tumor cells in vivo. Cancer Res, 43(1): 73-77

PMID

24 Spechler S J (2005). Barrett’s esophagus: a molecular perspective. Curr Gastroenterol Rep, 7(3): 177-181

PMID

25 Tang J Y, Chang H W, Chang J G (2013). Modulating roles of amiloride in irradiation-induced antiproliferative effects in glioblastoma multiforme cells involving Akt phosphorylation and the alternative splicing of apoptotic genes. DNA Cell Biol, 32(9): 504-510

PMID

26 Tatsuta M, Iishi H, Baba M, Uehara H, Nakaizumi A, Taniguchi H (1993). Inhibition by amiloride of gastric carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in Wistar rats. Br J Cancer, 67(5): 1011-1014

PMID

27 Tatsuta M, Iishi H, Baba M, Yano H, Sakai N, Uehara H, Nakaizumi A (1997). Chemoprevention by amiloride against experimental hepatocarcinogenesis induced by Wnitrosomorpholine in Sprague-Dawley rats. Cancer Lett, 19(1): 109-113

28 Xu X C (2009). Risk factors and altered gene expression in esophageal cancer. In: Verma M editor, Cancer Epidemiology. New York: Humana press, pp335-360

29 Yamada T, Alpers D H, Laine L, Owyang C, Powell D W (1999). Textbook of gastroenterology. 3rd edition. Lippincott Williams and Wilkins: Philadelphia.